Gilead Sciences Inc - Company & Market Research Reports

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.


The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment - Product Thumbnail Image

The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment

  • Report
  • 320 Pages
From
World Market for Anti-Infectives: Antifungals, Antibacterials and Antivirals (Treatments for HIV, HBV, HCV, Urinary Tract, Respiratory, Candidiasis and Other Infections) - Product Thumbnail Image

World Market for Anti-Infectives: Antifungals, Antibacterials and Antivirals (Treatments for HIV, HBV, HCV, Urinary Tract, Respiratory, Candidiasis and Other Infections)

  • Report
  • 220 Pages
From
The 2018-2023 World Outlook for Hepatitis C Treatments - Product Thumbnail Image

The 2018-2023 World Outlook for Hepatitis C Treatments

  • Report
  • 293 Pages
The 2018-2023 World Outlook for Hepatitis C Therapies - Product Thumbnail Image

The 2018-2023 World Outlook for Hepatitis C Therapies

  • Drug Pipelines
  • 293 Pages
 What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other]) - Product Thumbnail Image

What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other])

  • Report
  • 203 Pages
From
Global HIV Infection Drug Market & Pipeline Insight - Product Thumbnail Image

Global HIV Infection Drug Market & Pipeline Insight

  • Drug Pipelines
  • 1350 Pages
From
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2017 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2017

  • Report
  • 980 Pages
From
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2017 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2017

  • Report
  • 919 Pages
From
HIV 1 Integrase (EC 2.7.7.) - Pipeline Review, H2 2016 - Product Thumbnail Image

HIV 1 Integrase (EC 2.7.7.) - Pipeline Review, H2 2016

  • Report
  • 60 Pages
From
PharmaPoint: Human Immunodeficiency Virus (HIV) - Global Drug Forecast and Market Analysis to 2025 - Product Thumbnail Image

PharmaPoint: Human Immunodeficiency Virus (HIV) - Global Drug Forecast and Market Analysis to 2025

  • Report
  • 365 Pages
From
HIV / AIDS - Pipeline Review, H1 2016 - Product Thumbnail Image

HIV / AIDS - Pipeline Review, H1 2016

  • Report
  • 886 Pages
From
HIV-1 Integrase (EC 2.7.7.) - Pipeline Review, H1 2016 - Product Thumbnail Image

HIV-1 Integrase (EC 2.7.7.) - Pipeline Review, H1 2016

  • Report
  • 70 Pages
From
HIV-1 Infection - Pipeline Review, H2 2015 - Product Thumbnail Image

HIV-1 Infection - Pipeline Review, H2 2015

  • Report
  • 406 Pages
From
HIV Drugs - Global Strategic Business Report - Product Thumbnail Image

HIV Drugs - Global Strategic Business Report

  • Report
  • 484 Pages
From
HIV / AIDS - Pipeline Review, H2 2015 - Product Thumbnail Image

HIV / AIDS - Pipeline Review, H2 2015

  • Report
  • 916 Pages
From
HIV / AIDS - Pipeline Review, H1 2015 - Product Thumbnail Image

HIV / AIDS - Pipeline Review, H1 2015

  • Report
  • 871 Pages
From
HIV-1 Infection - Pipeline Review, H1 2015 - Product Thumbnail Image

HIV-1 Infection - Pipeline Review, H1 2015

  • Report
  • 319 Pages
From
The 2018-2023 World Outlook for HIV and AIDS Therapeutics - Product Thumbnail Image

The 2018-2023 World Outlook for HIV and AIDS Therapeutics

  • Report
  • 293 Pages
Global Hepatitis Drug Market & Clinical Trials Insight 2023 - Product Thumbnail Image

Global Hepatitis Drug Market & Clinical Trials Insight 2023

  • Report
  • 550 Pages
From
Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global - Product Thumbnail Image

Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global

  • Report
  • 87 Pages
From
Loading Indicator
adroll